The Oxford/AstraZeneca coronavirus vaccine only offers limited protection against the South African strain of the coronavirus, a study due to be released on Monday shows.
“A two-dose regimen of [the vaccine] did not show protection against mild-moderate Covid-19 due to [the South African variant]”, the study says, as quoted by The Financial Times.
Continue reading https://sptnkne.ws/FpsW